Permanent alterations of drug metabolizing enzymes and of c myc oncogene in carcinogenesis of rat and mouse liver
Muenzel, P.; Steiling, W.; Bock Hennig, B.S.; Fischer, G.; Bock, K.W.
Journal of Cancer Research and Clinical Oncology 113(Suppl): S12
1987
ISSN/ISBN: 0171-5216
Accession: 028881430
PDF emailed within 1 workday: $29.90
Related References
Lu, L.; Shi, J.; Li, Q.; Peng, X.; Dong, L.; Li, Y.; Dai, P.; Wang, Y.; Guo, E.; Zhou, F.; Liu, Z. 2014: Effects of liver diseases on drug-metabolizing enzymes: implications for drug fate alterations and nano-therapeutic openings Current Medicinal Chemistry 21(22): 2522-2541Leber, H.W.; Rawer, P.; Harders, A.; Schutterle, G. 1971: Spironolactone induced alterations in microsomal drug metabolizing enzymes of the liver European Journal of Clinical Investigation 1(5): 379
VandenBranden, M.; Wrighton, S.A.; Ekins, S.; Gillespie, J.S.; Binkley, S.N.; Ring, B.J.; Gadberry, M.G.; Mullins, D.C.; Strom, S.C.; Jensen, C.B. 1998: Alterations of the catalytic activities of drug-metabolizing enzymes in cultures of human liver slices Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(11): 1063-1068
Cojocel, C.; Mayer, D. 1989: Depletion of cytochrome P-450 and alterations in activities of drug metabolizing enzymes by S-(1,2-dichlorovinyl)-L-cysteine in mouse kidney cortex Archives of Toxicology. Supplement. 13: 417-421
Lucier, G.W.; McDaniel, O.S. 1972: Alterations in rat liver microsomal and lysosomal -glucuronidase by compounds which induce hepatic drug metabolizing enzymes Biochimica et Biophysica Acta 261(1): 168-176
Lucier, G W.; McDaniel, O S. 1972: Alterations in rat liver microsomal and lysosomal β-glucuronidase by compounds which induce hepatic drug-metabolizing enzymes Biochimica et Biophysica Acta - General Subjects 261(1): 168-176
Leonard, T.B.; Popp, J.A.; Graichen, M.E.; Dent, J.G. 1981: Alpha-Naphthylisothiocyanate induced alterations in hepatic drug metabolizing enzymes and liver morphology: implications concerning anticarcinogenesis Carcinogenesis 2(6): 473-482
Sharma, O.P.; Shukla, R.P.; Singh, C.; Sen, A.B. 1978: Drug metabolizing enzymes in mouse liver infected with Plasmodium berghei Indian Journal of Parasitology 2(1): 29-30
Ueng, T.H.; Wang, H.W.; Chiang, L.Y. 1999: Inhibition of drug-metabolizing enzymes in mouse liver by a water soluble fullerene C60 Taiwan-Japan Cooperative Meeting of Fullerene Science and Technology (2 ) 7(4): 681-694
Ghazal, A.; Mahfouz, M.; Makar, A.B.; Ghoneim, M.T. 1974: Effect of schistosomal infection and of schistosomicidal drugs on the drug metabolizing enzymes of mouse liver Naunyn-Schmiedeberg's Archives of Pharmacology 282(2): 181-186
Teras, L.E.; Kildema, L.A.; Birk, R.V. 1983: Alterations in carbohydrate metabolizing enzymes induced by hormones during the process of carcinogenesis Iarc Scientific Publications 51: 285-293
Wu, K.C.; Cui, J.Y.; Klaassen, C.D. 2012: Effect of graded Nrf2 activation on phase-i and -Ii drug metabolizing enzymes and transporters in mouse liver Plos one 7(7): E39006
Mikhailova, O.N.; Gulyaeva, L.F.; Filipenko, M.L. 2005: Gene expression of drug metabolizing enzymes in adult and aged mouse liver: a modulation by immobilization stress Toxicology 210(2-3): 189-196
Nishimura, M.; Yoshitsugu, H.; Yokoi, T.; Tateno, C.; Kataoka, M.; Horie, T.; Yoshizato, K.; Naito, S. 2005: Evaluation of mRNA expression of human drug-metabolizing enzymes and transporters in chimeric mouse with humanized liver Xenobiotica; the Fate of Foreign Compounds in Biological Systems 35(9): 877-890
Batra, J.K.; Raj, H.G.; Subramanian, T.A. 1987: Effect of cord factor, a toxic glycolipid from Mycobacterium tuberculosis, on mouse liver drug metabolizing enzymes Toxicon: Official Journal of the International Society on Toxinology 25(3): 345-349